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           The actuality and importance of the approached problem: Fungal rhinosinusitis (FRS) 
is an important pathological entity, an extremely controversial topic in today's medical world for 
the various directions of research it offers [1, 2, 3]. In recent years, the incidence of FRS has 
increased significantly, possibly due to air pollution, increased allergies, climate change and 
contemporary diagnostic methods [2, 4, 5]. Currently, the RSF classification includes: invasive 
forms with three subtypes (acute RSFI, chronic RSFI and granulomatous RSFI) and non-invasive 
forms with two forms (fungus ball and allergic RSF) [6, 7, 8, 9].  
Fungus ball (FB) of the paranasal sinuses is the most common subtype of RSF, defined as 
chronic non-invasive RSF, without allergic mucin, which usually develops in immunocompetent 
individuals [4, 6]. Complete removal of the lesion and adequate drainage of the sinus by 
endoscopic surgery is the preferred therapeutic approach for the treatment of this condition with 
a low recurrence rate after surgery [10]. 
Despite the recognition of FRS as a serious entity for over two centuries and all the 
studies that have taken place in recent years, the disease remains a controversial disease, with 
evasive pathophysiology, incomplete knowledge of epidemiology and medical mycology. 
Further research is needed to elucidate the exact etiological and pathogenetic role of fungal 
species in chronic rhinosinusitis (CRS), perfecting the diagnosis and treatment of FRS for a 
better prognosis [3, 6, 11].  
Based on the above, we set the next purpose of research – a prospective comparative 
study of microbiological, histopathological features and functionality of nasal pseudostratified 
ciliated epithelium in vitro in patients with FB of the maxillary sinus to optimize the diagnosis 
and treatment. 
In order to achieve this purpose, the following research objectives were stipulated:  
1. The study of the morbidity rate of fungus ball of the maxillary sinus in the variety of 
rhinosinusal diseases.  
2. Determination of the functionality of the mucociliary epithelium in vitro (optical 
microscopy) and histopathological particularities in patients with fungus ball of the maxillary 
sinus.  
3. Establishing the diversity of microbiological agents involved in fungus ball of the 
maxillary sinus.  
4. Development of a standardized diagnostic and treatment algorithm for patients with 
fungus ball of the maxillary sinus.  
The general methodology of the research was developed based on the publications of 
local authors [12, 13] and abroad [6, 14, 15, 16]. For the research and solution of the problems 
approached in the thesis we used the methods: analytical, historical, clinical, anamnestic, 
paraclinical, statistical, mathematical, monitoring and evaluation. 
To achieve the purpose and objectives of the research we proposed to perform two 
studies: 1) a retrospective study which evaluated the epidemiological aspects of fungus ball in 
the spectrum of rhinosinusal diseases and 2) a prospective comparative study which analyzed the 
microbiological, histopathological features and functionality of the pseudostratified ciliated 
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epithelium in vitro in patients with fungus ball of the maxillary sinus for the correct adjustment 
of the diagnostic and treatment protocol. 
 
Scientific novelty of the obtained results: 
1. We analyzed the characteristic of clinical forms and the diversity of microbiological agents 
involved in fungus ball of the maxillary sinus. 
2. We estimated the importance and efficiency of optical microscopy and histopathological 
examinations in the clinical approach of patients with fungus ball of the maxillary sinus. 
3. We studied the dynamic evolution of the nasal functional state and the nasal pseudostratified 
ciliated epithelium in vitro in patients with fungus ball of the maxillary sinus for the correct 
adjustment of the diagnosis and treatment protocol. 
4. We proposed criteria for conservative treatment of the fungus ball of the maxillary sinus, 
complementary to surgical treatment, depending on the functionality of the mucociliary 
epithelium. 
5. We performed a demanding monitoring on the evolution and prognosis of patients with fungus 
ball of the maxillary sinus, depending on the methods of conservative treatment associated with 
surgical treatment. 
The applicative value of the paper consists in the elaboration of a standardized diagnosis 
and treatment algorithm for patients with fungus ball of the maxillary sinus and its 
implementation in the national clinical protocol. 
Approval of the thesis results. The results of the study were presented and discussed in 
the following national and international scientific forums: 
• XXX Marius S. Plouzhnikov International Conference of Young Otorhinolaryngologists. May 
23, 2018, St. Petersburg, Russian Federation. Awarded with first place in the Rhinology 
category. 
• National ENT Conference with international participation “Updates in the diagnosis and 
treatment of ENT diseases, May 17, 2019, Chisinau, Moldova. 
• 5th Congress of the Romanian Rhinology Society, September 4-7, Eforie Nord, Romania, 
2019. 
• Conference of the Days of the State University of Medicine and Pharmacy "Nicolae 
Testemitanu", October 17, 2019, Chisinau, Moldova. 
The thesis was discussed and approved at the Meeting of the Department of 
Otorhinolaryngology of IP USMF "Nicolae Testemitanu" (verbal process no. 7 from 24.06.2020) 
and at the Meeting of the Scientific Seminar of Otorhinolaryngology-Ophtalmology (verbal 
process no. 12 from 03.07.2020). 
The opinion of the Research Ethics Committee for the research study (verbal process no. 
65 of June 17, 2016) was positive. 
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FRS is a clinical condition with various manifestations, ranging from simple colonization 
to acute invasion, a disease with confusion and controversy over its exact pathogenesis and 
effective treatment, which should be considered in all immunocompromised patients and all 
patients with CRS [1, 9, 18]. Fungal infections of the paranasal sinuses can manifest as two 
distinct entities. Invasive forms include 3 subtypes: acute invasive fungal rhinosinusitis (IFRS), 
chronic RSFI and granulomatous IFRS. Non-invasive forms include 2 subtypes: FB and allergic 
FRS (AFRS). The most severe (invasive) infections occur in patients with compromised 
immunity and are relatively easily recognized by the extent of symptoms and sudden evolution. 
The mortality rate is quite high in the case of IFRS, and early diagnosis and appropriate 
treatment are vital [19]. Non-invasive infections are chronic and, unfortunately, are often 
confused and treated for long periods of time as bacterial CRS, until the exact recognition of the 
etiology of the disease [1, 6, 7, 20]. However, each form of FRS has a characteristic clinical 
presentation and evolution, and the immune status of the host plays a critical pathophysiological 
role. The correct diagnosis and early initiation of treatment allow to obtain optimal results, 
avoiding the development of complications or a fatal result [9, 18, 21]. 
The diagnosis of FRS is primarily histological. The distinction between IFRS and non-
invasive FRS is based on histopathological evidence of fungal invasion of the sinus mucosa and 
bone, and possibly spread to adjacent structures and tissues (orbit, anterior skull base and 
pterygopalatine fossa). In non-invasive FRS the fungal infection is limited to the sinus cavity, 
without fungal invasion of the mucous membrane and bones. However, a clinical-radiological 
correlation is required in the exact diagnosis of FRS, a condition that frequently misleads [10, 
19]. 
FRS treatment is divided into two main directions: 1) surgical treatment, which aims to 
eliminate the fungal antigen, and is, most commonly, the main treatment and 2) conservative 
treatment, which tries to prevent recurrences, but is not standardized so far and there is no clear 
evidence of the efficacy of any of the therapeutic agents used. Sinus endoscopic surgery is used 
in conjunction with long-term conservative treatment, oral and intranasal glucocorticosteroids, 
immunotherapy, antifungal medication, and antimicrobial agents [22]. 
An increasing amount of scientific evidence suggests that herbal medicines may be 
helpful as an adjunctive and auxiliary treatment in rhinosinusitis. Sinupret® (Bionorica, 
Neumarkt, Germany) was developed by phytoneering processes, which allows a higher 
concentration and purification of active ingredients in plants, used to maintain the normal 
function of sinus cavity membranes. The preparation contains active ingredients in the form of 
powder from 5 plants, is available in the form of pills or solution, has a complex action 
(mucolytic, bronchodilator, anti-inflammatory, antiviral, antibacterial, secretolytic and 
immunostimulant), a low level of side effects and is effective for the treatment of rhinosinusitis 
[23, 24]. 
Sinupret has been widely used in Europe for over 70 years in the treatment of respiratory 
diseases, associated with inadequate mucociliary clearance (CMC) - as a mucoactive agent for 
acute rhinosinusitis or CRS - and has an excellent safety and efficacy profile. Sinupret is an 
important adjuvant that provides a faster and clinically relevant remission of symptoms, imaging 
and ultrasonographic findings and improves quality of life, thus improving the results of 





1.2. Diagnosis and contemporary management of non-invasive fungal rhinosinusitis 
 
Fungus ball of the paranasal sinuses is a distinct clinical entity, a discrete non-invasive 
form, localized, not at all or slightly aggressive, extramucosal, occurring especially in 
immunocompetent patients and defined as an accumulation of dense fungal elements in the 
cavity of a single sinus. The condition occurs more frequently in elderly patients, with a mean 
age of 64 years, and is predominantly female. Classically, the disease involves a single paranasal 
sinus in over 90% of cases, most commonly the maxillary sinus [6, 20, 25, 26]. The condition 
has been identified in 4-26%, and according to recent studies data about 0.29-5.4% of all cases of 
inflammatory CRS undergoing surgery [4, 28]. However, the incidence of FB in recent years has 
shown a marked increase, and an occasional decrease in immunity may be the cause of the 
transformation of this condition into an invasive form [6, 20, 25, 26].  
The most commonly involved pathogen is Aspergillus (in 90-96% of cases), mainly 
Aspergillus fumigatus (in 93% of cases), less frequently Aspergillus flavus, Aspergillus niger and 
Aspergillus nidulans. In second place are the species Mucorales and much less often other 
species of fungi are detected [6, 25, 29]. The pathophysiology of FB remains largely unknown 
and more research on this issue is indispensable. For the development of the disease, 2 
conditions are necessary: the penetration of the hyphae and fungal spores into a paranasal sinus 
and the creation of the environment that contributes to the growth of fungi. These conditions 
occur when some pathologies disrupt normal CMC and/or obstruct the sinus ostium. 3 possible 
theories of FB development have been suggested: aerogenic, odontogenic and mixed [26, 28]. 
The clinical picture in patients with FB is nonspecific, often identical to the symptoms in 
paucisymptomatic, recurrent bacterial CRS, resistant to antibiotic treatment (observed in 58.5% 
of patients). Characteristic imaging findings and histopathological examination confirm the 
diagnosis. Calcifications and/or erosion of the inner wall of the sinus on computed tomography 
(CT) scanning are considered the most specific signs and have a strong suggestive role for a 
correct diagnosis. The histopathological image is characteristic - luminal aggregation of fungal 
hyphae [6, 20, 25, 26]. 
FB is usually diagnosed occasionally during bacterial CRS treatment. Positive diagnosis 
of FB of the paranasal sinuses is established based on clinical-pathological criteria, suggested by 
deShazo: 
1. Imaging evidence of sinus opacification with or without the association of flocculating 
calcifications.  
2. Mucopurulent material such as syrup or clay in a sinus.  
3. A dull and dense conglomeration of hyphae (fungal ball), separated from the 
respiratory mucosa of the sinus.  
4. Chronic non-specific inflammatory response of varying intensity in the mucosa 
adjacent to the fungal elements (the response may include lymphocytes, plasma cells, mast cells 
and eosinophils, but allergic mucin, granulomas and predominance of eosinophils are absent).  
5. Absence of histological evidence of fungal invasion of the mucosa, blood vessels or 
bone, visualized microscopically in staining for fungi [21, 27, 28].  
The purpose of treating patients with FB is surgical ablation of the mass of the fungal 
hyphae with restoration of drainage and ventilation of the affected sinus. In most cases, the 
condition is managed by endoscopic techniques [9, 18, 22]. Both intraoperatively and 
postoperatively, it is essential to irrigate the sinuses with saline solutions, which increase CMC, 
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facilitate the elimination of mucous secretions and the removal of any fungal residues [26, 27, 
28, 29]. Also, intraoperative cortisone instillations can be used intraoperatively (due to the anti-
inflammatory effect) [26, 28, 29]. Because FB is a non-invasive form of FRS and the outcome of 
surgical treatment is usually excellent, systemic or topical antifungal treatment is rarely required 
[22, 26, 28, 29]. 
Therefore, the diagnosis of FB is often delayed, because the symptoms are generally 
similar to those of bacterial CRS, the evolution of the disease is slow, oligosymptomatic and 
non-invasive [29]. FB should be suspected in immunocompetent and non-atopic patients with 
recurrent or resistant unilateral sinusitis. CT scan is the imaging examination of choice with 
typical, non-pathognomonic, signs that include heterogeneous opacification of the affected sinus, 
usually the maxillary sinus, associated with hyperdense foci, and uncommon sinus bone wall 
sclerosis [18, 27, 28] . Medical history, clinical examination, endoscopic examination and 
imaging examination present valuable information only for the suspicion of FB, the definitive 
diagnosis is based on macroscopic evaluation, biopsy and histopathological examination of 
surgical pieces [6]. Endoscopic sinus surgery is the basic treatment with excellent results and 
limited morbidity that does not require local or systemic antifungal treatment [18, 27, 28]. 
Allergic fungal rhinosinusitis is a clinically distinct and common form of RSF with the 
formation of nasal polyps, an immunologically mediated non-invasive fungal inflammation, a 
chronic, hypertrophic and stubborn (refractory) sinus disease, with a marked propensity for 
recurrence. The disease is characterized by the accumulation of allergic fungal mucin in the nasal 
sinuses, hypersensitivity type I (allergic reaction to extramucosal fungi in the sinus cavity), 
characteristic histological image and a predilection for mucus formation and bone erosion [6, 18, 
30]. 
The major diagnostic criteria for AFRS are: a) eosinophilic/allergic mucin, often with 
Charcot-Leyden crystals, no evidence of tissue fungal invasion, b) the presence of fungi under 
direct microscopy, no fungal invasion in sinus tissue, or sinus content culture, c) PN with an 
incidence ranging from 75% to 100% of cases, d) characteristic imaging signs that reflect the 
structure of the growths developed in the sinuses and e) type I hypersensitivity to fungi (history, 
skin or serological tests). However, not all 5 criteria are necessary for the diagnosis of AFRS. In 
some cases, the macroscopic appearance of eosinophilic mucus is sufficient for diagnosis, in 
other cases it is considered positive fungal cultures of nasal or sinus mucus in the absence of 
appropriate fungal elements. Some authors dispute the need to demonstrate a fungal allergy. 
Recently, a group of international experts redefined RSFA as “histological confirmation of 
eosinophilic mucus and the presence of type I fungal hypersensitivity in patients with CRS” [20, 
30]. 
The other 6 criteria are minor: 1) history of asthma, 2) unilateral predominance, 3) 
imaging evidence of bone erosion, 4) positive rhinosinusal fungal culture, 5) presence of 
Charcot-Leyden crystals in samples taken during surgery and 6) eosinophilia serum [2, 6]. 
Therefore, RSFA is a unique entity with controversies in classification, pathogenesis, 
diagnostic criteria and management protocols. The condition usually occurs in young, 
immunocompetent patients who often have a history of atopy, including allergic rhinitis and/or 
asthma, or a long-term clinical picture of CRS, refractory to antibiotic treatment. Nasal polyps 
are present in almost all patients, and extra-sinus complications - in a proportion of patients. The 
composition of inflammatory cells in the mucous membranes is mainly characterized by 
eosinophils and lymphocytes [18, 30]. The disease is a complex interaction of IgE-mediated 
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systemic / local hypersensitivity to fungal antigens, host defense mechanisms (innate and 
adaptive) and possibly superantigens. There is usually involvement of several sinuses, including 
pansinusitis and rhinitis. The condition tends to be bilateral and there is a common nasal 
component. The diagnosis of RSFA combines clinical, radiological, microbiological and 
pathological examination, but the definitive diagnosis can be made only by examining surgical 
specimens - the characteristic appearance of eosinophilic mucin is the safest indicator of RSFA 
[6, 7, 18, 30]. RSFA management is largely surgical along with an important role for oral 
corticosteroids and a developing role for immunotherapy and antifungal remedies [2]. 
 
1.3. Clinical features of diagnosis and treatment of invasive fungal rhinosinusitis 
 
            RSFI is a condition that requires emergency diagnosis and early treatment due to the vital 
and functional prognosis reserved for initiating aggressive surgical and systemic antifungal 
treatment. Essentially, this condition occurs in immunocompromised patients - with neutropenia, 
who administer immunosuppressive therapy, with malignant hematological diseases, with organ 
and bone marrow transplantation, infected with advanced human immunodeficiency virus, 
corticosteroids, with diabetes and malnutrition. Much less frequently (but cases are reported), 
RSFI can occur in immunocompetent individuals. Thus, most patients with RSFI already have 
poor physical development, due to previous diseases or associated with treatment, and the 
prognosis is reserved and high mortality. In addition, these factors contribute to difficulties in the 
diagnosis and treatment of RSFI, which can progress rapidly with significant disorders [6, 25].  
           The following diagnostic criteria are proposed for the diagnosis of RSFI: 1) rhinosinusitis 
confirmed on imaging examination, 2) histopathological evidence of fungal invasion of the 
mucosa, submucosa, blood vessels or bones of the paranasal sinuses and 3) necrotic tissue with 
minimal infiltration of inflammatory cells [6, 8, 25]. 
Acute invasive fungal rhinosinusitis is generally a rare condition, but the most 
dangerous form of FRS and the most common form of IFRS, with an evolution of up to 4 weeks, 
which occurs in patients with immunocompromised status, progresses rapidly, puts in life-
threatening and requires immediate medical attention. Patients with this disease previously had 
survival rates of 20-75%, which correlates with the control of the underlying condition. Recent 
studies have shown, along with improved diagnosis, treatment and prophylaxis (active 
surveillance of the high-risk population, reversal of neutropenia and other causes of 
immunosuppression, reversal of diabetic ketoacidosis, prompt aggressive surgical debridement 
and systemic antifungal chemotherapy), amelioration of relief mortality from 50-80% to about 
18% [9, 18, 20].  
Chronic invasive fungal rhinosinusitis, unlike acute IFRS, is much rarer, progresses 
over a longer period (4 to 12 weeks or more) and has a much slower destructive process. 
Insidious progression takes place over several months to years, in which fungal organisms 
invade the mucosa, submucosa, blood vessels and bone walls of the paranasal sinuses. Extension 
to the vascular network or adjacent structures and inflammatory reactions are very rare. The most 
affected are the ethmoid bone or sphenoid sinuses, but can involve any paranasal sinuses [9, 18, 
20]. 
             Granulomatous invasive fungal rhinosinusitis, also known as primary paranasal 
granuloma and indolent FRS, is found in patients with an easily identifiable immune deficiency. 
The evolution is slowly progressive, longer than 12 weeks and can last from a few months to 
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several years, and symptoms include chronic migraines and gradual edema of the face, until 
vision can be affected [7, 20].  
In conclusion, FRS is a common condition, the main clinical manifestations include 
nasal congestion, purulent or bloody rhinorrhea, headache and/or a feeling of impaired sense of 
smell. In recent years, the incidence of FRS has increased considerably, due to increasing 
numbers and diversity of pathogenic fungi involved in the disease, increasing life expectancy of 
the population, contemporary diagnostic equipment and increasing the frequency of conditions 
that favor fungal infections. Currently, 5 types of FRS are recognized: non-invasive (FB, AFRS) 
and invasive (acute IFRS, chronic IFRS, granulomatous IFRS). Each of the FRS subtypes has a 
different clinical presentation, distinct from other forms and partially overlapping, is associated 
with unique imaging features and specific treatment. The diagnosis of RSF is primarily 
histological. The distinction between RSFI and non-invasive RSF is based on histopathological 
evidence of fungal invasion of the sinus mucosa, bone, blood vessels, and possibly spread to 
adjacent structures and tissues (orbit, anterior skull base, and pterygopalatine fossa). In non-
invasive FRS the fungal infection is limited to the sinus cavity. Effective management of FRS 
requires correct diagnosis and histological classification, because the evolution, treatment and 
prognosis of FRS caused by different species, especially Aspergillus and Mucorales, are 
radically different. Treatment includes complete removal of the lesion and proper drainage of the 
sinus by surgery, combined with antifungal and immunomodulatory treatment. 
 
STUDY MATERIAL AND METHODS 
 
The work was performed within the Department of Otorhinolaryngology of the State 
University of Medicine and Pharmacy "Nicolae Testemitanu". The research was carried out in 
the Department of Functional Surgery, Speech Therapy and Otorhinolaryngological Recovery of 
the Public Medical-Sanitary Institution Republican Clinical Hospital "Timofei Moşneaga", the 
laboratory of the Department of Histology, Cytology and Embryology of the Public Institution 
State University of Medicine and Pharmacy "Nicolae Testemitanu" and laboratory Synevo in 
accordance with the methods applied or developed [17]. 
In order to achieve the research purpose and objectives, we set out to conduct two 
studies: a prospective study and a retrospective study. The retrospective study evaluated the 
epidemiological aspects of FB in the spectrum of rhinosinusal disorders. In order to determine 
the incidence of FB among hospital rhinosinusal diseases, we selected all patients with 
rhinosinusal diseases, treated during 2011-2015 in the Department of Functional Surgery, Speech 
Therapy and Otorhinolaryngological Recovery of the Public Medical-Sanitary Institution of the 
Republican Clinical Hospital "Timofei Mosneaga". The prospective study was conducted at the 
Department of Otorhinolaryngology of the Public Institution State University of Medicine and 
Pharmacy "Nicolae Testemitanu" and in the Department of Functional Surgery, Speech Therapy 
and ENT Recovery of the Public Medical-Sanitary Institution Republican Clinical Hospital 
"Timofei Moşneaga" during 2016- 2019. 
The prospective comparative study of the microbiological, histopathological features and 
functionality of the nasal pseudostratified ciliated epithelium in vitro in patients with FB of the 
maxillary sinus to optimize the diagnosis and treatment protocol was performed on a group of 60 
adult patients aged 18-68 years with FB of the maxillary sinus. We divided the general study 
group into 2 sublots: 1) study group 1 (30 patients) treated by functional endoscopic sinus 
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surgery (FESS) and conservative (washing with saline and topical vasoconstrictor solutions); 2) 
study group 2 (30 patients) treated with FESS and conservative (lavage with saline solutions, 
topical vasoconstrictors and Sinupret oral extract until and after FESS). 
The study protocol was approved by the Ethics Committee of IP USMF "Nicolae 
Testemitanu". Informed consent was obtained from each patient prior to inclusion in the study. 
All patients were informed about the benefits and risks of surgery and conservative treatment for 
FB of the maxillary sinus. 
We used the following methods of investigation: clinical, laboratory, special laboratory 
(microbiological examination, histopathological examination, cytological examination, optical 
microscopy examination), instrumental (nasal endoscopy), imaging (radiological examination, 
computed tomography of the paranasal sinuses with score estimation Lund-Mackay, magnetic 
resonance imaging), evaluation of quality of life using the SNOT-22 questionnaire, evaluation of 
olfactory function through questionnaires. 
Primary data processing was performed using the functions and modules of the 
"Statistical Package for the Social Science" (SPSS) version 16.0 for Windows (SPSS Inc., 
Belmont, CA, USA, 2008) and Microsoft Office Excel on the personal computer through 
statistical procedures. descriptive (frequency tables, graphs, numerical indicators - lowest and 
highest values, average, average error, etc.) and inferential (assessing the characteristics of a 
population and testing statistical hypotheses). The 't' test for independent samples was used to 
estimate the significant differences between the means of two groups. The dynamics of the group 
mean values was evaluated by the "t" test for pair-samples. Contingency table data were 
analyzed by the method of variational statistics (χ²). Differences with bilateral value p <0.05 
were considered statistically significant. 
 
3. DIAGNOSIS AND TREATMENT OF PATIENTS WITH FUNGUS BALL OF THE 
MAXILLARY SINUS 
3.1. The morbidity rate of fungus ball of the maxillary sinus in the variety of rhinosinusal 
diseases 
 
            During 2011-2015 in the Department of Functional Surgery, Speech Therapy and 
Otorhinolaryngological Recovery of the Public Medical-Sanitary Institution Republican Clinical 
Hospital "Timofei Moşneaga" were admitted, diagnosed and treated 7696 patients with 
rhinosinusal disorders, including 51 patients with FB, cumulative prevalence of 0.66%. Against 
the background of a relatively stable annual number of patients with rhinosinusal diseases, the 
number of patients with FB of the maxillary sinus increases (from 0.07% in 2011 to 0.13% in 
2012, 0.32% in 2013, 1.11% in 2014 to 1.67% in 2015), a fact probably explained by alerting 
clinicians to the presence of fungi, improving diagnostic methods, correct guidance of clinicians 
in making the diagnosis and differential diagnosis of RSF. 
 
3.2. Patients with maxillary sinus fungus ball treated with FESS and conservative 
       (washing with saline solutions, topical vasoconstrictors) 
 
            The mean age of the patients in study group 1 was 42 ± 2 years. In this group 
predominated women (70.0%) and people working in the field of work (90.0%). Harmful factors 
at work found 25.9% and a history of rhinosinusal pathology - all 100.0% patients. 
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            The onset of the disease was slow in all patients with FB of the maxillary sinus. Most 
commonly, patients reported nasal discharge or rhinorrhea (100.0%), headache (100.0%), 
difficult nasal breathing (96.7%), pain in the maxillary sinus region with irradiation in the teeth 
of the maxillary arch (93.3 %), pain in the projection of the affected maxillary sinus (86.7%), 
permanent nasal obstruction (70.0%) and foreign body sensation in the nasal cavity (66.7%). 
Objective examination noted nasal secretions (100.0%), olfactory disorders (100.0%), difficult 
nasal breathing (93.3%), sensitivity to palpation (93.3%), closed rhinolalia (63.3%) and soft 
tissue edema in the cheek region (70.0%). Nasal endoscopy found nasal mucosa and affected 
middle nasal horns (100.0%), nasal secretions (100.0%) and hypertrophy of the unciform 
apophysis (63.3%). 
            In patients in study group 1, the laboratory examination revealed altered hemoleukogram 
(60.0%), bacterial flora (80.0%) and fungal agents (63.3%) in nasal secretion. The nasal mucus 
content included fungal conglomerates (56.7%), neutrophils (60.1%) and eosinophils (10.0%). 
The most common changes on CT examination were opacification of the maxillary sinuses 
(100.0%), blockage of the ostiomeatal complex (63.3%) and opacification of ethmoidal cells 
(26.7%). 
Conservative treatment until hospitalization was administered in 100.0% and topical 
glucocorticosteroids - 70.0% patients in study group 1. All patients in this study group 
underwent treatment by antrostomy with FB ablation, combined with other surgical methods 
(anterior ethmoidotomy, submucosal resection of nasal cornets, septoplasty). The vast majority 
of patients (90.0%) were satisfied with the outcome of treatment and showed a favorable 
postoperative evolution (improvement of nasal respiration, restoration of smell, absence of pre-
hospitalization complaints, increased ciliary beats frequency (CBF), reduced severity of 
symptoms). 
Histopathological examination found disorders of the integrity of the mucociliary 
epithelium in 60.0% of cases, infiltration with inflammatory cells (polymorphonuclear and 
mononuclear) of the mucociliary epithelium, lamina propria, submucosa and periglandular space 
(100.0%), disorders of the alveolar glands 90.0 % and blood vessel disorders 90.0%. 
Histopathological examination in FB was positive in 66.7% of cases. 
 
3.3. Patients with maxillary sinus fungus ball treated with FESS and conservative (wshing 
with saline solutions, topical vasoconstrictors, Sinupret oral extract until and after FESS) 
 
            The mean age of the patients in study group 2 was 40 ± 2 years. In this group 
predominated women (76.7%) and people working in the field of work (76.7%). Harmful factors 
at work were found by 43.5% of patients and a history of rhinosinusal pathology - all 100.0% of 
patients.  
The onset of the disease was slow in all patients with FB of the maxillary sinus. The most 
common charges were difficult nasal breathing (100.0%), nasal discharge or rhinorrhea (96.7%), 
pain in the affected maxillary sinus region (96.7%), headache (93.3%), pain in the region 
maxillary sinus with irradiation in the teeth of the maxillary arch (86.7%), permanent nasal 
obstruction (66.7%) and foreign body sensation (66.7%). Objective examination noted nasal 
secretions of various types (100.0%), olfactory disorders (100.0%), difficult nasal breathing 
(96.7%), sensitivity to palpation (93.3%), closed rhinolalia (60, 0%) and soft tissue edema in the 
cheek region (56.7%). Nasal endoscopy found damage to the nasal mucosa and middle nasal 
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turbinates (100.0%), nasal secretions (100.0%) and hypertrophy of the unciform apophysis 
(36.7%).  
In the patients from group 2 of the study, the laboratory examination found modified 
hemoleukogram (43.3%), bacterial flora (60.0%) and fungal agents (60.0%) in the nasal 
secretion. The nasal mucus content included fungal (60.0%) and neutrophil (40.0%) 
conglomerates. On CT examination, opacification of the maxillary sinuses (100.0%), blocked 
ostiomeatal complex (73.3%) and opacification of ethmoidal cells (40.0%) were detected. 
Conservative treatment until hospitalization was administered by all 100.0% of patients 
and topical glucocorticosteroids - 70.0% of patients. All patients in this study group underwent 
antrostomy treatment with FB extraction, combined with other surgical methods (anterior 
ethmoidotomy, posterior ethmoidotomy, total ethmoidotomy, left unilateral submucosal 
resection of the left nasal turbinate, submucosal resection of the nasal turbinate) and septum. All 
patients (100.0%) were satisfied with the outcome of treatment, showed a favorable 
postoperative evolution (improvement of nasal respiration, restoration of smell, absence of pre-
hospitalization complaints, increased CBF, reduced severity of symptoms and lack of 
postoperative complications). Histopathological examination found disorders of the integrity of 
the mucociliary epithelium (73.3%), infiltration with inflammatory cells (polymorphonuclear and 
mononuclear) of the mucociliary epithelium, lamina propria, submucosa and periglandular space 
(100.0%), disorders of the alveolar glands (86, 7%) and disorders of blood vessels (93.3%). 
Histopathological examination of FB was positive in 63.3% of cases. 
 
3.4. Efficacy of treatment in patients with maxillary sinus fungus ball treated with FESS 
and conservative (lavage with saline solutions, topical vasoconstrictors or lavage with saline 
solutions, topical vasoconstrictors, Sinupret oral extract before and after FESS) 
 
The study groups were similar depending on the socio-demographic characteristics (sex, 
education, living environment, work activity, workplace), risk factors of FB (hereditary 
rhinosinusal history, pathological history, occupational noxious factors), history medical 
(systemic conservative treatment, local conservative treatment, frequency of rhinosinusogenic 
complications), clinical picture (onset of the disease, frequency of accusations, prevalence of 
concomitant diseases), results of otorhinolaryngological examination (objective, laboratory and 
instrumental), current surgical treatment, histopathological examination and postoperative 
evolution (figure 1, 2, 3). 
Patients in study group 1, compared to patients in study group 2, had statistically 
significantly more frequent uncinate process hypertrophy (63.3% and 36.7%, respectively; p 
<0.05), (63.3% and 36.7%, respectively; p <0.05), although the analysis according to location 
did not find statistically significant differences. Caseous nasal secretions (16.7% and 0%, 
respectively; p <0.05), determined on inspection, and the mean value of the Lund-Mackay score 
(2.8 ± 0.5 and 1.5 ± 0.4; p <0.05), determined imagistically, were found to be statistically 
significantly more frequent in patients in study group 2 (Figure 4). 
Although palpation sensitivity was generally similar in both study groups, sensitivity in the right 
canine fossa (66.7% and 36.7%, respectively; p <0.05) was statistically significantly higher in 
patients in the study group 1, and sensitivity in the canine fossa left (66.7% and 36.7%, 
respectively; p <0.05) - statistically significantly more frequent in patients of study group 2.  
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This fact can be explained by the higher frequency of damage to the maxillary sinus in 
each study group. 
 
 
Figure 1. Diagnostic and treatment protocol. A - patient, 48 years old. Fungus ball of the 
left maxillary sinus with specific metallic calcifications. B - surgical method: left maxillary 
antrostomy with maxillary fungus ball ablation, migration of the fungal body in the region 
of the left ostiomeatal complex. 
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  Figure 3. Frequency of clinical manifestations (%) at the objective otorhinolaryngological 
examination in patients of the study groups. 
 
 
                   
                    Figura 4. Fungal hyphae: A – Aspergillus fumigatus, B – Aspergillus niger. 
 
Frequency of culture determination of the mycotic agent in nasal secretion, determination 
of mycotic agent by direct mycological examination and histopathological examination, content 
pathological content of the nasal secretions, the CT scanograms modifications were similar in 
both study groups. 
 
Figura 5. Mycotic agents (absolute numbers) detected on culture media 
in patients of the study groups. 
 
Despite similar parameters, from a statistical point of view of the favorable postoperative 
evolution and satisfaction with the treatment result in patients in both study groups, in patients of 
study group 2 there was a tendency to increase of these parameters, but did not reach statistical 
certainty. 
Histopathological examination showed no statistically significant differences in both 
groups, except for mucociliary epithelial hyperplasia (60.0% and 26.7%, respectively; p <0.05) 
and mucoid degeneration in large areas (40.0% and 13, 3%, respectively; p <0.05), which were 
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Figure 6. Tissue fragments of the maxillary sinus mucosa taken intraoperatively. 
Hematoxylin-eosin staining. A - microphotogram x20; B –microphotogram x10 
 
Statistically significant differences were revealed in the evaluation of FBC, determined in vitro, 
after one month post-treatment: FBC of 1-5 Hz was statistically significantly higher in patients in 
study group 1 (26.7% and 3.3%, respectively, p <0.01), and the mean value of FBC (12.07 ± 0.3 
Hz and 6.87 ± 0.3 Hz; p <0.001) and FBC> 5 Hz (96.7% and 73, 3%, respectively; p <0.01) were 
statistically significantly higher in patients in study group 2 (figure 7). 
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Figure 8. A - phase contrast optical microscopy of the cells of the nasal mucociliary 
epithelium, in active phase of movement (x40); B - phase contrast optical microscopy of the 
nasal mucociliary epithelium, in the active phase of movement (x40). 
 
The evaluation of the quality of life according to the SNOT-22 questionnaire revealed 
higher scores in both study groups (mainly> 60 points), and the average value of the SNOT-22 
score (92.33 ± 1.1 points and 70.0 ± 2.8 points; p <0.001) and the score 81-100 points (83.3% 
and 56.7%, respectively; p <0.05) were statistically significantly more common in patients in 
study group 1 ( figure 22). Surgical treatment of patients with FB contributed to a statistically 
significant reduction in the severity of symptoms in both study groups: 1 month after treatment, 
scores> 60 points disappeared and lower scores were found, mostly 0-20 points.  
 
 
Fig 9. Quality of life at hospitalization, assessed according to the questionnaire 
SNOT, in patients of the study groups 
However, the mean value of the SNOT-22 score (3.0 ± 0.5 points and 17.4 ± 2.7 points; p 
<0.001) was statistically significantly lower and the score 0-20 points (96.7% and 76.7%, 
respectively; p <0.05) was statistically significantly more frequent in patients of study group 2, 
and the score was 21-60 points - statistically significantly more common in patients of study 
group 1 (23, 3% and 3.3%, respectively; p <0.05) (figure 9).  
 
SUMMARY OF THE RESEARCH RESULTS 
 
FB of the maxillary sinus is the most common form of chronic RSF in adults, usually 
with unilateral involvement, with a predominance of females and among immunocompetent 
people. Although the etiology, pathogenesis and natural history of RSF have been extensively 
studied, especially in relation to the cytokine profile, inflammatory and remodeling processes, 
they are far from being fully understood. For this purpose, additional molecular, macroscopic, 
experimental and epidemiological studies are needed [11, 28]. 
Clinical presentation and endoscopic findings are nonspecific, and cultures are often 
negative. CT imaging suggests, by characteristic signs, a correct diagnosis, which is based on 
histological identification of fungal hyphae. FB treatment of the maxillary sinus is surgical with 
conservative postoperative treatment. Our experience confirms the concept that a purely 
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effective treatment in patients with FB of the maxillary sinus. Sinupret brings its clinical 
benefits, at least in part, by stimulating the secretion of Cl- transepitelial, FBC and CMC. 
Increasing fluid and electrolyte secretion is a means of improving CMC in people with FB of the 
maxillary sinus. Because FB is a non-invasive form of FRS and has a very low rate of 
postoperative complications, systemic and/or topical antifungal treatment is not indicated [28]. 
The SNOT-22 questionnaire is a useful tool for quantifying the change in symptoms and can be 
used to predict the extent of postoperative improvement [42, 58, 60, 119]. Based on data from 
the literature and the results of our study, we developed the following algorithm for standardized 





































Level of primary health care and specialized outpatient health care 
 
Addressing symptoms: 
1. Repeated rhinosinusal disorders, refractory to drug treatment, predominantly 
unilateral. 
2. Periodic, persistent headache. 
3. Facial pain located unilateral in the projection of the maxillary sinus and upper teeth. 
4. Difficult nasal breathing, predominantly unilateral. 
5. Mucopurulent or purulent rhinorrhea, predominantly posterior, unilateral. 
6. Odor disorders. 
  
Level of specialized outpatient care (ENT)  
 
1. Objective ENT examination (nasal 
endoscopy): hyperemia and edema of the 
nasal mucosa unilaterally, reactive 
hypertrophy of CNI, CNM; nasal polyps 
in MNM with uncinate process 
hypertrophy; partial migration of the 
fungus ball in the region of the OM 
complex.  
2. Complementary dental examination. 
 
Computed tomography of the paranasal 
sinuses 
 
1. In 90% of cases partial or total 
heterogeneous opacification of the 
involved sinus. 
2. Microcalcifiers or “spots” with dense 





Level of specialized outpatient (ENT) and 
primary care 
 
1. Dynamic monitoring with the 
administration of the phytoproduct 
Sinupret extract until complete 
rhinosinusal functional restoration 
(SNOT-22: 0-20 points).  
2.    Immunological consultation. 
3. Repeated ENT control over 3,6,12 
months in patients with 
histomorphologically confirmed 





Level of specialized hospital care 
 
1. Surgical treatment by FESS. 
2. Histopathological examination of FB 
material and maxillary sinus mucosa. 
3. Microbiological examination of sinus 
contents. 
4. Administration of the phytoproduct 
Sinupret extract pre- and postoperatively. 




















1. Impairment of the integrity of the mucociliary epithelium leads in evolution to characteristic 
chronic histopathological changes, with disruption of the function of mucociliary clearance and 
alteration of the inflammatory phases necessary for the functionality of the nasal mucosa. 
2. The morbidity rate of patients with fungus ball of the maxillary sinus among patients with 
rhinosinusal disorders was 0.66%. Against the background of a relatively stable annual number 
of patients with rhinosinusal diseases, the number of patients with fungus ball of the maxillary 
sinus increases: from 0.07% in 2011 to 1.67% in 2015, which can probably be explained by 
alerting otorhinolaryngologists to the presence of fungi, improving diagnostic methods, correct 
guidance of clinicians in concretizing the diagnosis and differential diagnosis of fungal 
rhinosinusitis. 
3. Statistically significant differences were found in the evaluation of the dynamic activity of the 
mucociliary epithelium determined in vitro, after one month post-treatment: the frequency of 
ciliary movements was statistically significantly higher in patients in study group 2 (12.07 ± 
0.29; p <0.01), compared to group 1 (6.87 ± 0.33). Videomicroscopic examination of the 
mucociliary epithelium revealed the complete restoration of the integrity of the epithelium and 
its dynamic activity, according to its physiological pattern. In the case of study group 1, the 
dynamic pattern showed altered ciliary movements and alternating mobile phases of cell cilia 
compared to group 2. Histopathological examination did not show statistically significant 
differences in both groups of our study, except mucociliary epithelial hyperplasia and 
degeneration mucoids in large areas. The presence of squamous cell metaplasia epithelial 
changes attests the need to use histopathological examination to establish the evolution and 
prognosis of this clinical entity. 
4. In the general group of patients with fungus ball of the maxillary sinus of our study, the fungal 
flora detected included: Aspergillus fumigatus, Aspergillus flavus, Candida albicans, Penicilium, 
Aspergillus niger and Aspergillus nidulans. The most common bacterial agents were: 
Staphylococcus aureus, Citrobacter Koseri, Haemophilus influenzae, Pseudomonas aeruginosa, 
Moraxella catarrhalis, Klebsiella oxytoca, Proteus vulgaris, Escherichia coli, etc. 
5. Medication with Sinupret improves the clinical picture of patients and restores the functional 
activity of the postoperative mucociliary epithelium, determining a prevalence of increased 
ciliary movement in patients in study group 2, but does not substantially change the 
histopathological pattern of maxillary sinus mucosa affected by  chronic inflammation. Restoring 
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the function of the mucociliary epithelium is the basic condition in improving the quality of life 




1. It is recommended for general physicians and otolaryngologists to use the phytoproduct 
Sinupret extract in the pre- and postoperative protocol in order to restore the pattern of the 
condition and functional activity of the nasal mucociliary epithelium in patients with fungal 
rhinosinusitis. 
2. CT examination of the nasal and nasal sinuses is recommended in patients treated with chronic 
rhinosinusitis, resistant to antibacterial treatment, in order to early diagnosis of fungal 
rhinosinusitis and conduct effective treatment. 
3. It is recommended to otolaryngologists in university clinics, the use of pre- and postoperative 
optical videomicroscopy, in patients diagnosed with fungus ball in order to monitor the 
functionality of the nasal mucociliary epithelium, minimizing the risks of relapses with a 
promising postoperative clinical evolution. 
4. It is recommended to otolaryngologists in hospital care to introduce histopathological 
examinations in patients with fungus ball of the maxillary sinus to assess the risks of squamous 
cell metaplasia and appropriate postoperative clinical monitoring. 
5. It is recommended to otolaryngologists in hospital care to use the histopathological method as 
a true and reliable diagnostic method in patients with fungus ball of the maxillary sinus to 
establish the causal etiological agents and assess the degree of tissue invasion, for a correct 
clinical classification of fungal rhinosinusitis. 
6. It is recommended to otolaryngologists to use the SNOT-22 questionnaire to quantify the 
change in clinical symptoms and monitor the postoperative condition, establishing correct 
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